To improve how patients, providers and research sponsors connect, Epic’s new Life Sciences program is designed to expand clinical trial access to more patients and better support the development of new research.
WHY IT MATTERS
The current disparate systems used for clinical studies can be tedious for patients and providers, according to Epic’s announcement.
Epic is testing the new data-driven program, which will initially focus on clinical…